U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Neurological Disorders and Stroke announces the availability of funding for implementation of the Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Pharmacodynamics and In Vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products (R21/R33). The purpose of this grant is to conduct pharmacodynamics, pharmacokinetics, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological disorders. Contractors should refer to Section VII, Agency Contacts, in the RFP for information regarding each . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | December 12, 2014

Federal Government Announces IGNITE: Pharmacodynamics and In Vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products (R21/R33) Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member